MTARC1 and metabolic dysfunction-associated steatotic liver disease: In addition, this is the first study to investigates the relationship between the rs738409 (PNPLA3), rs58542926 (TM6SF2), rs1260326 and rs780094 (GCKR), rs641738 (MBOAT7), rs72613567 (HSD17B13), and rs2642438 (MTARC1) polymorphisms in the Brazilian population with MASLD and hepatic fibrosis.